Ozzie D, NP-hard 
Preliminary surveillance suggests the 2024-2025 trivalent #FluVaccines have been about as effective as usual.
What is added by this report?
Interim 2024–2025 seasonal influenza VE estimates were derived from four U.S. VE networks. Among children and adolescents, VE was 32%, 59%, and 60% in outpatient settings (three networks) and 63% and 78% against influenza-associated hospitalization (two networks). Among adults, VE was 36% and 54% in outpatient settings (two networks) and 41% and 55% against influenza-associated hospitalization (two networks).
What are the implications for public health practice?
Vaccination with the 2024–2025 influenza vaccine reduced the risk for influenza-associated outpatient visits and hospitalization. These findings support recommendations that all eligible persons aged ≥6 months should receive an annual influenza vaccination. Vaccination should be offered as long as influenza viruses are circulating.
https://www.cdc.gov/mmwr/volumes/74/wr/mm7406a2.htm
(So nice to see #MMWR back!)
